Dr. Martin Gignac obtained his medical degree from McGill University in 1998 and completed his training in psychiatry at the Université de Montréal in 2003. He completed a fellowship in pediatric psychopharmacology at Massachusetts General Hospital, an affiliate of Boston’s Harvard Medical School in the United States in 2003-2005. He has since been working as child and adolescent psychiatrist in the field of severe dysruptive disorders (ADHD, ODD, CD, SUD) at the Intitut Philippe-Pinel in Montreal. He is currently appointed as the Head of the child and adolescent psychiatry division of the Psychiatry Department at McGill University and the chief of child and adolescent psychiatry at the McGill University Health Center, Montreal Child Hospital. In addition, he is the Chair of the CADDRA Board since 2019. He he has has been speaking at national and international conference, involved in several studies and published articles and book chapters in the field of pediatric psychopharmacology.